Dr. Sandra M. Reiken, MSW, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 14 Ashwood Trl, Boonton, NJ 07005 Phone: 973-714-6659 |
Dr. Lynn Abels, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 130 Powerville Rd, Boonton, NJ 07005 Phone: 973-316-1915 Fax: 973-299-5431 |
Dr. Randolph Scott Shipon, PH.D., NCC, LPC Psychologist Medicare: Accepting Medicare Assignments Practice Location: 550 W Main St, Boonton, NJ 07005 Phone: 215-906-3967 Fax: 973-300-1443 |
Dr. Maureen Mcgreal, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 159 Ridgeview Pl, Boonton, NJ 07005 Phone: 973-335-3695 |
Dr. Irit Vita Felsen, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 550 W Main St, Boonton, NJ 07005 Phone: 973-541-9900 Fax: 973-263-3547 |
Dr. Wilda Mesias, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 550 West Main St, Boonton, NJ 07005 Phone: 973-307-8045 Fax: 973-586-8353 |
Dr. Jessica Platt, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 130 Powerville Rd, Boonton, NJ 07005 Phone: 973-299-5400 |
News Archive
The well-reported arsenic contamination of drinking water in Bangladesh called the "largest mass poisoning of a population in history" by the World Health Organization and known to be responsible for a host of slow-developing diseases has now been shown to have an immediate and toxic effect on the struggling nation's economy.
Children exposed to paternal tobacco smoking before birth are more likely to develop asthma - and associated changes to immune genes predict the level of risk.
New research from Boston Medical Center finds that using clear, unambiguous language when recommending HPV vaccination both increases vaccine acceptance and increases conversation efficiency while preserving patient satisfaction.
Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a Mayo Clinic researcher who co-led PERSIST-1, the worldwide phase III clinical trial that tested the therapy. Specifically, pacritinib substantially reduced severe enlargement of the spleen, a typical feature of advanced myelofibrosis, in more than 20 percent of patients and alleviated debilitating side effects in more than 46 percent.
An international research team led by University of Pittsburgh Cancer Institute (UPCI) scientists discovered that by preventing cancer cells from entering a state of cellular sleep, cancer drugs are more effective, and there is a lower chance of cancer recurrence.
› Verified 7 days ago